載入...
Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients
BACKGROUND: Heparin administration in COVID-19 patients is recommended by expert consensus, although evidence about dosage, duration and efficacy are limited. We aim to investigate the association between different dosages of low molecular weight heparin (LMWH) and mortality among COVID-19 hospitali...
Na minha lista:
| 發表在: | Front Pharmacol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7424043/ https://ncbi.nlm.nih.gov/pubmed/32848743 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.01124 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|